Bonk, Inc. (NASDAQ:BNKK – Get Free Report) Director Mitchell Austin Rudy acquired 7,500 shares of the firm’s stock in a transaction dated Monday, June 22nd. The stock was bought at an average cost of $1.56 per share, for a total transaction of $11,700.00. Following the purchase, the director directly owned 73,341 shares of the company’s stock, valued at approximately $114,411.96. This trade represents a 11.39% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
Mitchell Austin Rudy also recently made the following trade(s):
- On Tuesday, June 16th, Mitchell Austin Rudy acquired 2,500 shares of Bonk stock. The shares were bought at an average price of $1.32 per share, with a total value of $3,300.00.
- On Wednesday, June 10th, Mitchell Austin Rudy bought 12,000 shares of Bonk stock. The stock was purchased at an average cost of $1.37 per share, with a total value of $16,440.00.
- On Thursday, April 9th, Mitchell Austin Rudy bought 31,055 shares of Bonk stock. The shares were purchased at an average price of $2.82 per share, for a total transaction of $87,575.10.
Bonk Trading Up 1.3%
NASDAQ BNKK opened at $1.56 on Thursday. Bonk, Inc. has a 12 month low of $1.25 and a 12 month high of $46.90. The stock has a market cap of $12.48 million, a price-to-earnings ratio of -0.34 and a beta of 1.85. The company’s 50 day moving average is $2.09 and its two-hundred day moving average is $2.99.
Hedge Funds Weigh In On Bonk
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in BNKK. State Street Corp bought a new stake in Bonk in the 4th quarter worth approximately $33,000. Steward Partners Investment Advisory LLC purchased a new stake in shares of Bonk during the 4th quarter worth approximately $37,000. Jane Street Group LLC bought a new position in shares of Bonk during the 4th quarter valued at approximately $96,000. Finally, Geode Capital Management LLC bought a new position in shares of Bonk during the 4th quarter valued at approximately $128,000. 12.55% of the stock is owned by institutional investors.
Analysts Set New Price Targets
BNKK has been the subject of several recent analyst reports. Wall Street Zen downgraded shares of Bonk from a “hold” rating to a “sell” rating in a report on Sunday. Weiss Ratings cut Bonk from a “sell (d-)” rating to a “sell (e+)” rating in a report on Wednesday, April 29th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, Bonk has an average rating of “Sell”.
Check Out Our Latest Research Report on Bonk
Bonk Company Profile
Safety Shot, Inc, a wellness and functional beverage company, engages in the research and development of over-the-counter products and intellectual property. Its products pipeline includes Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women’s sexual wellness; NoStingz, a jellyfish sting prevention sunscreen; and JW-110 for the treatment of atopic dermatitis/eczema. The company primarily sell its products through third-party physical retail stores and partners. The company was formerly known as Jupiter Wellness, Inc and changed its name to Safety Shot, Inc in September 2023.
See Also
- Five stocks we like better than Bonk
- Why KB Home Could Reward Patient Investors Later
- Meta’s Internal Turmoil: Morale Nears 20-Year Low at the Wrong Time
- Tesla’s New NHTSA Probe Lands at the Worst Possible Time
- Nano Nuclear’s AI Data Center Deal Puts the Stock Back in Focus
Receive News & Ratings for Bonk Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bonk and related companies with MarketBeat.com's FREE daily email newsletter.
